HC Wainwright & Co. Maintains Buy on Adicet Bio, Raises Price Target to $34

HC Wainwright & Co. analyst Robert Burns has maintained a Buy rating on Adicet Bio (NASDAQ: ACET) and increased the price target from $27 to $34.